Media advisory - Government of Canada to announce support for researchers and projects at universities across Canada
MONTRÉAL, March 12, 2024 /CNW/ - The Honourable Pablo Rodriguez, Minister of Transport and Quebec lieutenant, on behalf of the Honourable François-Philippe Champagne, Minister of Innovation, Science and Industry, and the Honourable Mark Holland, Minister of Health, will announce support awarded to researchers and projects at institutions across Canada and highlight the Government of Canada's support for Canada's research community.
The Minister will be joined by Professor Alejandro Adem, President of the Natural Sciences and Engineering Research Council of Canada (NSERC) and Chair of the Canada Research Coordinating Committee, and Daniel Jutras, Université de Montréal's Rector. Researchers from the Université de Montréal will also showcase their funded projects.
Date: Wednesday, March 13, 2024
Time: 9:30 am (ET)
Location: Montréal, Quebec
Note to media
\Members of the media are asked to contact ISED Media Relations at [email protected] to confirm their attendance and receive event location details.
TIME has named Yale School of Medicine immunobiologist Dr. Akiko Iwasaki to the 2024 TIME100 Health, the magazine's annual list of the 100 most influential people in global health care. She was also named last week to the TIME100, TIME's list of the...
Richards Packaging Income Fund (the "Fund") announced that the five nominees listed in the management information circular for the 2024 Annual Meeting of Unitholders were elected as Trustees of the Fund at the annual general meeting held in Toronto,...
An Illinois utility watchdog group has joined forces with a community that has had highly publicized problems with lead in its drinking water to file testimony arguing that Aqua Illinois' proposed $19.2 million rate hike should be slashed by at least...
Tarcocimab clinical and non-clinical data highlight strong 6-month efficacy profile in diabetic retinopathy patients and continued favorable safety profile.KSI-501 clinical and non-clinical data highlight multiple ascending dose safety, bioactivity...
Select Medical Holdings Corporation ("Select Medical," "we," "us," or "our") today announced results for its first quarter ended March 31, 2024, and the declaration of a cash dividend.
For the first quarter ended March 31, 2024, revenue increased...
